Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $95.9000 (-1.62%) ($95.0000 - $97.6800) on Thu. Aug. 22, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.75% (three month average) | RSI | 51 | Latest Price | $95.9000(-1.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.9% a day on average for past five trading days. | Weekly Trend | LGND advances 2.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.375% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-15%) IFRA(-9%) UUP(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.375% (StdDev 2.75%) | Hourly BBV | 0 () | Intraday Trend | -1.7% | | | |
|
5 Day Moving Average | $96.22(-0.33%) | 10 Day Moving Average | $94.64(1.33%) | 20 Day Moving Average | $95.09(0.85%) | To recent high | -20.2% | To recent low | 7.1% | Market Cap | $1.541b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |